{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:19:57Z","timestamp":1771481997676,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Quantification of I-123-ioflupane uptake using modern SPECT\/CT improves diagnostic accuracy for disorders affecting the nigrostriatal pathway. This study assessed whether absolute and relative standardized uptake values (SUV) could distinguish dementia with Lewy bodies (DLB) from non-DLB in patients with suspected DLB and explored associations with core clinical features, including visual hallucinations (VH) and REM sleep behavior disorder (RBD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-four patients (mean age 71.5\u2009\u00b1\u20099.26 years; 39% female) were retrospectively included. All underwent I-123-ioflupane SPECT\/CT imaging with both iterative (Flash 3D) and quantitative reconstructions. SUVmax, SUVmean, and relative SUV (rSUV) values were extracted for the caudate, putamen, and striatum. Uptake metrics were compared between DLB and non-DLB groups and analyzed in relation to clinical features, including visual hallucinations (VH) and REM sleep behavior disorder (RBD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Visual assessment classified 28\/74 scans (38%) as abnormal (sensitivity 90%, specificity 80%, AUC 0.846). Quantitative SUVmax in the striatum and putamen showed the highest diagnostic performance (AUC up to 0.83). Striatal SUVmax remained an independent predictor of DLB in multivariable analysis (OR\u2009=\u20090.58,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Patients with VH had significantly lower striatal SUVmax than those without (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), with an optimal cutoff of \u2264\u20096.0\u00a0g\/mL (AUC\u2009=\u20090.70, sensitivity 64.3%, specificity 80.4%). No significant differences were observed for RBD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Quantitative I-123-ioflupane uptake assessment using SUV measures offers clinically relevant diagnostic value for differentiating DLB from other neurodegenerative diseases. It also helps in identifying patients with visual hallucinations, supporting the broader integration of SUV-based dopaminergic imaging into clinical workflows.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-025-07680-7","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:21:07Z","timestamp":1764231667000},"page":"2777-2785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contribution of quantitative I-123-ioflupane SPECT\/CT to the differential diagnosis of dementia with lewy bodies"],"prefix":"10.1007","volume":"53","author":[{"given":"George Karun","family":"Kurian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Salvioni","family":"Chiabotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemie","family":"Lejay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Perriraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Rouaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Depeursinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Nicod Lalonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklaus","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Allali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-1374","authenticated-orcid":false,"given":"John O.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Jreige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"7680_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386:1683\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(15)00462-6.","journal-title":"Lancet"},{"key":"7680_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2022.101441","volume":"69","author":"S Prasad","year":"2023","unstructured":"Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, et al. Recent advances in Lewy body dementia: a comprehensive review. Disease-a-Month. 2023;69:101441. https:\/\/doi.org\/10.1016\/j.disamonth.2022.101441.","journal-title":"Disease-a-Month"},{"key":"7680_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with lewy bodies. J Neurol. 2010;257:359\u201366. https:\/\/doi.org\/10.1007\/s00415-009-5324-y.","journal-title":"J Neurol"},{"key":"7680_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, et al. Dementia with lewy bodies: an update and outlook. Mol Neurodegener. 2019;14:5. https:\/\/doi.org\/10.1186\/s13024-019-0306-8.","journal-title":"Mol Neurodegener"},{"key":"7680_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"J-P Taylor","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157\u201369. https:\/\/doi.org\/10.1016\/S1474-4422(19)30153-X.","journal-title":"Lancet Neurol"},{"key":"7680_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"key":"7680_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with lewy bodies. Neurology. 2020;94:743\u201355. https:\/\/doi.org\/10.1212\/WNL.0000000000009323.","journal-title":"Neurology"},{"key":"7680_CR8","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s00259-023-06154-y","volume":"50","author":"M Jreige","year":"2023","unstructured":"Jreige M, Kurian GK, Perriraz J, Potheegadoo J, Bernasconi F, Stampacchia S, et al. The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with lewy bodies: an updated systematic review. Eur J Nucl Med Mol Imaging. 2023;50:1988\u20132035. https:\/\/doi.org\/10.1007\/s00259-023-06154-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7680_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/tomography10100119","volume":"10","author":"PH Kuo","year":"2024","unstructured":"Kuo PH, Cella P, Chou Y-H, Arkhipenko A, Fisher JM. Optimal DaTQUANT thresholds for diagnostic accuracy of dementia with lewy bodies (DLB) and parkinson\u2019s disease (PD). Tomography. 2024;10:1608\u201321. https:\/\/doi.org\/10.3390\/tomography10100119.","journal-title":"Tomography"},{"key":"7680_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00259-022-06069-0","volume":"50","author":"F Lanfranchi","year":"2023","unstructured":"Lanfranchi F, Arnaldi D, Miceli A, Mattioli P, D\u2019Amico F, Raffa S, et al. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of parkinson\u2019s disease (PD) and dementia with lewy bodies (DLB). Eur J Nucl Med Mol Imaging. 2023;50:1090\u2013102. https:\/\/doi.org\/10.1007\/s00259-022-06069-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7680_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11604-024-01648-7","volume":"43","author":"T Sato","year":"2025","unstructured":"Sato T, Sawai S, Shimada N. Comparison of the ability of different quantitative indices in 123I-FP-CIT single-photon emission computed tomography to differentiate dopaminergic neurodegenerative disease. Jpn J Radiol. 2025;43:78\u201390. https:\/\/doi.org\/10.1007\/s11604-024-01648-7.","journal-title":"Jpn J Radiol"},{"key":"7680_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/mds.27945","volume":"35","author":"M Huber","year":"2020","unstructured":"Huber M, Beyer L, Prix C, Sch\u00f6necker S, Palleis C, Rauchmann B, et al. Metabolic correlates of dopaminergic loss in dementia with Lewy bodies. Mov Disord. 2020;35:595\u2013605. https:\/\/doi.org\/10.1002\/mds.27945.","journal-title":"Mov Disord"},{"key":"7680_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2020.12.009","volume":"99","author":"T Miyagawa","year":"2021","unstructured":"Miyagawa T, Przybelski SA, Maltais D, Min H-K, Jordan L, Lesnick TG, et al. The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer\u2019s disease dementia. Neurobiol Aging. 2021;99:11\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.12.009.","journal-title":"Neurobiol Aging"},{"key":"7680_CR14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.938344","author":"B Alkharisi","year":"2023","unstructured":"Alkharisi B, Dostzada K, Kaur H, Kumar M, Wei JY, Azhar G. The importance of dopamine deficiency evaluation in Non-Alzheimer disease dementias. Am J Case Rep [Internet]. 2023. https:\/\/doi.org\/10.12659\/AJCR.938344. [cited 2024 Apr 1];24.","journal-title":"Am J Case Rep [Internet]"},{"key":"7680_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/ene.13390","volume":"24","author":"E Jaakkola","year":"2017","unstructured":"Jaakkola E, Joutsa J, M\u00e4kinen E, Johansson J, Kaasinen V. Ventral striatal dopaminergic defect is associated with hallucinations in parkinson\u2019s disease. Eur J Neurol. 2017;24:1341\u20137. https:\/\/doi.org\/10.1111\/ene.13390.","journal-title":"Eur J Neurol"},{"key":"7680_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00415-024-12799-y","volume":"272","author":"CE Cicero","year":"2025","unstructured":"Cicero CE, Terravecchia C, Tabb\u00ec S, Garofalo R, Luca A, Mostile G, et al. Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in parkinson\u2019s disease. J Neurol. 2025;272:75. https:\/\/doi.org\/10.1007\/s00415-024-12799-y.","journal-title":"J Neurol"},{"key":"7680_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jamda.2016.03.017","volume":"17","author":"I Zahirovic","year":"2016","unstructured":"Zahirovic I, Wattmo C, Torisson G, Minthon L, Londos E. Prevalence of dementia with lewy body symptoms: a cross-sectional study in 40 Swedish nursing homes. J Am Med Dir Assoc. 2016;17:706\u201311. https:\/\/doi.org\/10.1016\/j.jamda.2016.03.017.","journal-title":"J Am Med Dir Assoc"},{"key":"7680_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1590\/0004-282x-anp-2020-0247","volume":"79","author":"V Calil","year":"2021","unstructured":"Calil V, Sudo FK, Santiago-Bravo G, Lima MA, Mattos P. Anosognosia in dementia with lewy bodies: a systematic review. Arq Neuropsiquiatr. 2021;79:334\u201342. https:\/\/doi.org\/10.1590\/0004-282x-anp-2020-0247.","journal-title":"Arq Neuropsiquiatr"},{"key":"7680_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.nicl.2017.08.021","volume":"16","author":"A Rahmim","year":"2017","unstructured":"Rahmim A, Huang P, Shenkov N, Fotouhi S, Davoodi-Bojd E, Lu L, et al. <article-title update=\"added\">Improved prediction of outcome in Parkinson\u2019s disease using radiomics analysis of longitudinal DAT SPECT images. NeuroImage: Clinical. 2017;16:539\u201344. https:\/\/doi.org\/10.1016\/j.nicl.2017.08.021.","journal-title":"NeuroImage: Clinical"},{"key":"7680_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41824-024-00205-9","volume":"8","author":"S Saito","year":"2024","unstructured":"Saito S, Nakajima K, Komatsu J, Shibutani T, Wakabayashi H, Mori H, et al. Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology. EJNMMI Rep. 2024;8:15. https:\/\/doi.org\/10.1186\/s41824-024-00205-9.","journal-title":"EJNMMI Rep"},{"key":"7680_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P. The \u03b1-Synuclein origin and connectome model (SOC model) of parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. JPD. 2021;11:455\u201374. https:\/\/doi.org\/10.3233\/JPD-202481.","journal-title":"JPD"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07680-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:38:35Z","timestamp":1771479515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7680"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07680-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present research was conducted in accordance with the Declaration of Helsinki. The Approval Committee is the local Ethics Research Committee of the State of Vaud (Commission cantonale d'\u00e9thique de la recherche sur l'\u00eatre humain, CER-VD) approved the research protocol: CER-VD#2018-01513.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In our study, consent was not required as all the information is anonymized and the submission does not include images that may identify the persons involved. Thus the need for obtaining informed consent from the patients was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}